Europe newborn screening market is projected to register a healthy CAGR in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation:
By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Country (Germany, France, U.K., Spain, Italy, Switzerland, Netherlands, Russia, Turkey, Belgium, Rest of Europe)
Some of the major factors contributing to the growth of the market:
- Government endorsements related to neonatal screening
- Government projects supporting technological advancement in the field of newborn screening
Market Players:
The key market players for Europe newborn screening market are listed below:
- PerkinElmer Inc.
- Natus Medical Incorporated
- Trivitron Healthcare
- Baebies, Inc.
- Bio-Rad Laboratories, Inc.
- Danahar
- Hill-Rom Services Inc.
- Intelligent Hearing Systems
- Interacoustics A/S
- Masimo
- Medtronic
- Otodynamics Ltd
- Vivosonic Inc.
- ZenTech S.A.
- Others